- $911.09m
- $730.60m
- $100.25m
Beta Bionics Inc reports results for the quarter ended June 30 - Earnings Summary
Beta Bionics Inc expected to post a loss of 45 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
Diabetes device makers fall after CMS proposes bidding program changes
U.S. STOCKS ON THE MOVE-NIP Group, Hyatt, BioXcel Therapeutics
Diabetes device makers fall after CMS proposes bidding program changes
Brief: Beta Bionics Announces Agreement With Abbott
Beta Bionics Inc expected to post a loss of 48 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Maze Therapeutics, UFP Technologies, Itron
U.S. STOCKS ON THE MOVE-AxoGen, Portillo, Cisco Systems
U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPal
BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating
U.S. STOCKS ON THE MOVE-Starbucks, Bristol Myers Squibb, Home Depot
Wall Street bullish on insulin device maker Beta Bionics after IPO
Beta Bionics raises $204 mln in upsized US IPO